Barclays Maintains Equal-Weight on Exelixis, Raises Price Target to $49

Exelixis, Inc.

Exelixis, Inc.

EXEL

0.00

Barclays analyst Etzer Darout maintains Exelixis (NASDAQ: EXEL) with a Equal-Weight and raises the price target from $45 to $49.